Leukemia
CytRx to Present at BIO CEO & Investor Conference
Published in Oncology Business Week, February 26th, 2012
2012 FEB 26 -- CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David Haen will provide a business update at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, at 11:30 a.m. Eastern time (8:30 a.m. Pacific Time). The conference will be held at the Waldorf=Astoria hotel in New York City.
"We are looking forward to an exciting and eventful year as we advance development of our promising oncology compounds in multiple clinical trials," said Mr. Kriegsman. "Among the 2012 highlights, we...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Diablo Valley Oncology
Diablo Valley Oncology Supports Tobacco Tax - Glioblastomas
Del Mar Pharmaceuticals to Present New Pre-clinical Data Related to the Mechanism of VAL-083 at the AACR Annual Meeting in April 2012 - Adenocarcinomas
Atlas of Endoscopic Ultrasonography - Carcinomas
Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis Immunotherapy AGS-003 in Combination with Sunitinib in Patients with Metastatic Renal Cell Carcinoma mRCC - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
